FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Ventrus

Sort
E.g., 2013-05-20
E.g., 2013-05-20
Enter a comma separated list of user names.

Ventrus BioSciences, Inc. (Nasdaq:VTUS) announced that on November 14, 2011 it completed its acquisition of all rights and title to VEN 309 (iferanserin) from the licensor, Sam Amer & Co.

Ventrus BioSciences, Inc. (Nasdaq:VTUS) announced that on November 14, 2011 it completed its acquisition of all rights and title to VEN 309 (iferanserin) from the licensor, Sam Amer & Co.

ADVERTISE WITH US